Dr Shahram Kordasti detailing the “immunologic mess” in bone marrow failure conditions & how to target it therapeutically. Dr Kordasti has also been doing an amazing job in leading & organizing collaborative efforts to study, monitor & target immunobiome in #MDSsm through i4MDS group

It was a busy final day at #EHA2024, but I had a chance to spend time with Dr Neal Young and chat—excellent way of spending time before rushing to the airport. There are always new things to learn from him….

Another good intuitive illustration

Tempting :)

A session recorded during #EHA2024 on #MDS is now published by VJHemOnc. In this session, Sanam Loghavi, MD صنم لغوی 🔬🧬 and I discussed the need for an ‘immune-informed’ patient stratification. vjhemonc.com/event/mds-sess…

What is the i4MDS consortium, and how will it improve immune monitoring in MDS? 🤔🩸 🎥 Check out our fantastic session from #EHA2024 with leading experts Sanam Loghavi, MD صنم لغوی 🔬🧬 & Shahram Kordasti to find out! Watch here: 👉 ow.ly/6lvW50Suseg 👈 #MDSsm #ImmunOnc #HemOnc European Hematology Association

Royal College of Pathologists, quite obvious 😀

Go #England, Go 🏴󠁧󠁢󠁥󠁮󠁧󠁿 London is all about football today!

World-first guidelines will help clinicians measure the immune response in patients with Myelodysplastic syndromes, a type of blood cancer 🩸 The guidelines were formed by an international consortium of experts created and led by Shahram Kordasti kcl.ac.uk/news/kings-lea…

"EHA Perspectives on Emerging Technologies in Hematology". This was a collaborative work by a team of scientists and clinicians, and I contributed to the sections on immune effector cell therapy and multi-omics. #EHA2024 European Hematology Association ehaweb.org/congress/eha20…

NHS is appealing for people with O-type blood to urgently come forward and donate, bbc.co.uk/news/articles/…

We are aware of a video circulating on social media promoting an oximeter that falsely claims it was developed at the Trust. We have worked with Full Fact to confirm that this is fraudulent, and encourage people to report it to the platform. For more information👇

ASH rush is finally over! Phew!

Very pleased to share our work on development of natural language processing pipeline to assess cardiovascular risk and thrombotic complications in MPN. Machine learning approach allowing assessment of health records of >900 patients and >23000 documents onlinelibrary.wiley.com/doi/full/10.10…

Excited to see our NIH NHLBI National Cancer Institute review on allo-HCT in #VEXAS is now available in Annals of Hematology. link.springer.com/journal/277 Also ongoing is our phase II study looking at the outcomes in #HCT for VEXAS. clinicaltrials.gov/study/NCT05027… Bhavisha Patel Ajoy Dias Dennis Hickstein.

Our findings show these tools are suboptimal for blinded pathway discovery. So, we developed PET, revealing new insights into biomarkers and therapeutics. Details here: nature.com/articles/s4146… #Biomarkers #DrugDiscovery #CancerResearch

I encourage you to join me in supporting Dr. Mikkael A. Sekeres MD, MS for #ASH secretary. He’s an outstanding leader, physician, mentor, and patient advocate, with a long history of dedicated service to ASH. Cast your vote today! Every vote counts! 🗳️

Meet @theIACH Faculty during IACH Meeting 2024 iachlive.cme-congresses.com/faculty/

“Done my bit”

September is Blood Cancer Awareness Month. Connect the dots… #BloodCancerAwareness